Language selection

Search

Patent 2029018 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2029018
(54) English Title: ANALOGUES OF GONADOTROPIN RELEASING HORMONE
(54) French Title: ANALOGUES DE L'HORMONE LIBERANT DE LA GONADOTROPHINE
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • C07K 07/23 (2006.01)
  • A61K 38/00 (2006.01)
(72) Inventors :
  • MILLAR, ROBERT P. (South Africa)
  • MILLAR, ROBERT P. (South Africa)
(73) Owners :
  • ROBERT P. MILLAR
  • ROBERT P. MILLAR
(71) Applicants :
(74) Agent: ROBIC AGENCE PI S.E.C./ROBIC IP AGENCY LP
(74) Associate agent:
(45) Issued:
(22) Filed Date: 1990-10-31
(41) Open to Public Inspection: 1991-05-02
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
89/8317 (South Africa) 1989-11-01

Abstracts

English Abstract


ABSTRACT
This invention provides peptides which are chimaeric
analogues of naturally occuring vertebrate gonadotropin
releasing hormone wherein the amino acid at position 6 of the
peptide is a D-amino acid and peptides which are analogues of
vertebrate gonadotropin releasing hormones, also having a D-
amino acid at position 6. These peptides have agonist
properties relative to naturally occuring vertebrate
gonadotropin releasing hormones.


Claims

Note: Claims are shown in the official language in which they were submitted.


18
I CLAIM :
1. A peptide which is a chimaeric analogue of a naturally
occuring vertebrate gonadotropin releasing hormone of
the formula
<IMG>
wherein
<IMG>
with the proviso that when A is His, C is Leu, D is Arg
and E is Gly.NH2 then B is not D-Tyr.
2. A peptide according to claim 1 selected from the group
of:
<IMG>

19
<IMG>
3. A peptide which is an analogue of a vertebrate
gonadotropin releasing hormone selected from the group
of:
<IMG>

<IMG>
4. A peptide according to claim 1 for use in a method of
regulating the release of hormones in vertebrates.
5. A peptide according to claim 2 for use in a method of
regulating the release of hormones in vertebrates.
6. A peptide according to claim 3 for use in a method of
regulating the release of hormones in vertebrates.

Description

Note: Descriptions are shown in the official language in which they were submitted.


1 2a2~ ~018
AWALOGUES ~ ~ ONA~OTROPIN REL~ASING HOR~ONE.
~ _0~
Thi~5 in~arl ti~n ~el~t~s to novel p~ptides and to th~ir u~e~.
1, .
Gon~dotrop in r~lea~ing hormon~ (GnR~ a d~cap~p~ide whic:h
i~ s~cre~ ~d I by ~ hypo~l~ic r~qian o~ th~ brain.
M~ n go~dotropin r~le~ing ho~on~ ~as ~ ollowin~
~ino ~ic!l $~qu~nce p ~;lu- Hi3~ S~r- Tyr~ Gly- ~eu- Ar~-
Pro-Gly N H2 I There a~e how~ r va3~iant l~ m8 oi~ mammalian
GnR~ in ot he~ ~rQrt~ xate~, ~o~ Qxample ~i h and birds.
The ~llow in,g i~ a table in which the primary ~tru~u~es o~
GnE~Hs ~ol at~d from the brain~ of differ~nt vært~brat6!s i8
d~picted .
I
~l ~G~ r~ -8 ~T~
~alm~s~ p~ rp~ ~T~ ly~H
~1~3e~n ~ ~ s~7:s~ ~d ~ ~ Ty~
Gn~ and i~l~ an~logues ~timulate th~ ~el~aYe o~ pitul~ary
gonadotro~ ~ hor~c~n~s and 'ch~e in turn activ~te
~meto~en~ !55i 5 and ~teroid~gRn~ tha gon~. Incre~ed
r~ as~ oi g Dnadotropin hormoneE~ ha~ b~n ~hown ~o ~t~mula~
the rep~o ~u~ ,tiv~ pro~e~s ia~ animal~ and hen~ m~thods o~
inerea~in~ t I th~ ~elease o;E gon~dotro~n hor~aones ~a:s
~ppl1cn'cl-¦n in ~h- edical and agriauleU~al sphorqe.
:
.

21129ql8
GnRH i3 ~ ~il4 presen~ in, and ha~ e~f~3ct3 on, the pla<:enta,
~ntr~1 n~ ~rl )us o~yst~m, adren~1~, gonads, ~nd ma~ary tls~u~
in m~m~na1~ I a nd hence anR~ anA1ogues a1r30 h~v~ pot~ntlal in
rnedica1 ~ nd I vet~rin;lry ~pp1ications ln r~gu1ating the~e
tissu~s
It i~ th u~ ¦ de~ ble that fuxther and mox~a e~ective
analogue~ o~ GnRX b~3 found to increa~ or ~ll3cre~se ~ne
re1ease o~ g~nadotropin hormon~s in v~Lriou~ diffor~nt cl~6e~
of vert~b~ ~at~s.
~ttempt~ ~ la~ al~o been made to incrsas~ th~ gonadotropin
rel~!l3lng ~IC~ivitiQ'I3 0~ th~ various p~cimary v6!rte~rate GnI?Hs
in mamma~ .8 ! by incorpor~ting D-amin~ ~cid~ ~nto th~ir
~tru~u~
~n ~n ~rt lo~ in Endocrinolo~y, volume 12~, ,pag~o 18~0 tD
1840, 1~8~ I b~ J ~ X~ng et ~1 there ~ d~sclo~ed ~ ch~ erl~
~na~ o~ue ~ n~tural ly occurring ~erte~rate gonadotrop~n
~sleasing ho~one, pGlu-His-Trp-~er-H$s-~-Tyr ~u-Ax~ro-
aly.NH~.
Y ~1 ~
A~c:ording tol one ~3pect. of ~he invention ~her~ ~ pr~-vided a
peptide ~ ~hi~h i~ ~ chlmaeric an~1O~ue o~ ~ n~tux~lly
~ccu~ring ~ebr~ e gon~dotropin releaR~ng honmone o~ the
~ormula;
pG1u~ s-r ~rp--~r--A~B-C-D-P~o-E
wherein:
.

2029~118 ~
I i
~ t ~ H~ r ~yr
B ls D~Ar , ~-Ly~3 , D-Trp , D~Ala , D-Tyr , D N~l ~ 2 ), or D-tert-
but-Ser,
1~ ~eu ~ T~p ~
~ i~ Ar~, G~ rr, or IJeu: and
E is ~ly~l ~H2~ D-Al~.NH2, NEt or aza-Gly,
~ith the rgviEio that wh~n A ~ H~, C i~ L~u, D i~: Arg and
E i~ Cly.l 1~2ltl~ B i~ not I) ~r.
~y "chin~ r~c analogue~ i mean~ a vertel~rate gonadotropin
~elea~n~ hormone whereln one or more o~ th~ a~oino acid3 at
~o~itlon~ 5 ~ 7 or 8 are eubstitu~e~ with a di~erent am~.no
acid occ~ rr~ng in the corre~pondinq po~ition in anotht3r
natur~lly ~ r1ng vQrte~rat~ ~onad~t~opln rel~a~ing
hormone . , .
Pr~f~r~Rd pq¦pt~d~ accordin~ to ~h~ inv~ntion inc~lud~:
~Glu ~ Hi ~ Trp - S~r ~ H~ - D - Trp ~ ~u ~ A~g - Pro -
~ly N~2
' ~ '
pGlu ~^ Hl I ~rrp - Ser - Tyr ~ D - Trp ~ Trp - Arg - Pro -
Gly NH2
II
~Glu - ~i ~ Trp - ~er - Hi~ Trp - Trp - A~g ~ Pro -
G;ly NH2
,

2~29018 -1
1 ~ I
III
p~ H1~i - l~rP -~ ~er - l~yr - D - Trp - ~rp - Tyr - Pro
Gly NH2
~V
p~lu - Ri~ - 'rrp - Ser - q~rr - D - Ar~ - ~rp - q~y~ - Pro -
G~y NH2
`, V
pS~lu ~- H~ -I ~rp ~ Ser - Tyr - D - ~y~ - ~rrp - ~ryr - Pro -
Gly ~2
~X
palu ~ i - Trp - S~r ~ ~yr ~ y~ ~ Trp - Gln - Pro -
Gly NH2
I VII
pGlU ~i~ -I ~rp - Ser~ - ~yr - D ~ys 'rrp - L~U - Pro -
~l~r ~z l
I VI I
pGlU - H1E I ~ ~rP - ser Tyr - ~ - L~ Trp - Arg ~ Pro -
t;~ly NH2
I IX
pGlu ~ H~ Trp ~ Ser - Hi~i - D Arg - Trp - ~rq - P~o - :
aly ~H2
.
~n anoth~ r Lspe~t of ~he invention a pRp~id~ whi~h l~i ~n
~nalogue of ~ a vertebral:e gonadotrop~n rel~a iing hormon~3
having onl ~ qP the ~ollowirlg ~o~nulae i~ pro~idQd:
. . .
.

2029018 11
s I ~
P~31U ~ }~1~ ~ IT~ e~ - ~Y~ A1a ~ I~U - ~1n - Pro -
G1Y ~H2
I XIII
P~:1U ~ ~ S~r - Tyr - D ~ TrP - L~U - G~ n - PrO
N} :~
I XIV
,
p:;lu - Hi~ -` Trp - S~r - ~yr ~ D - P~rg - 'rrP - ~U - PrO -
Gl y NH2
~ XV
pGlU - H1L I q!rp - ser - H$5; ~ Trp ~ ~rrp - ryr - Pro -
~ly - M~Sz l
! XVI
pt:lu - Hi~ I ~ Trp - Ser - H1~ - D - Ly - ~ Tyr - P~O -
~ly N~lz l
XVII
~h~ p~p~i tleh o~ the învention have a~onlst propertie~
~lat~v~ ~o ~ a naturally occurrin~ vert~br~ gona~otr~pln
~le~ing h~ono .
In yet anc Ith-r a~p~t o~ the lnventl~ ther~ rovided th~
u~e o~ ~ . ~Qp~ld~ describe~ a~ov~ a~ a r~ul~tor ~or
~gul~tins I '¢h~ r0~ase o~ hormone~ in ve~ct~brAt~ ~nd ln
~arti~ul~ ^ ~h~ uE~e ~ a p~ptide of ~ny 0~3 th~ fe~x~ulae I~,
VI, ~7XII, I~ XVI or XVII ~ regulate ths~ r~lea~e Q~e
horr~or~e~ Ln !chlsk2ns.

1, '-., I 2029bl8 ~
Peptlde~ c ~ ~ho invention are dec: ap~ptidee havin~ A ~qUenae
c~X ten ~ no' ~c:ids. The ~ir~t amino acid in the sQquenc~
o~upie~ ~ o~l~lon one, the ~eoond zlmino acid in tho ~e~u~3nc~
oac1uple~ ~ ~ition two and ~imilarly for ~mino ac:lds 3 to 10 .
Ihe lnv~n :l~n provides ~ new ~et of ~n~H sn~logu~ wlt~
altered ac tlvity compar~d Wi~h native mammallan GnRH ~f ~oth
m~mal~n an~ non~amn~ n specie~. Some o~ the ~n~logue~
o~ 'thel in~ ron t~ on are chim~eric GnRH analogue6~ in which th~3
amino ~c:11 I ~ ,t one of the variable po~iti~ Alor1g tS~ ten
amino ~ d ~s~u~nc:e, nam~ly po~ition~ 5, 7 or 8, 1~
~ub6~itu~ Id w~th a di~feren'c amino acid whlch ~ac~urs in tne
~ame posi ~ic ~n in another ~ertebrate ~:n~ rhe ¢himaeric
~nalogue~s ~ the inventic~n ~ur~he~ ina;:rpor~e a D~ no acsid
at po~iti~ ~n 6 ~n ~h~ir amlno acid ~equenel ~he chima~ic
an~logue~ ~nay al~o h~ ~ui~stitut3d a~ the c:arboxy'l terminu~
~th N-~t lyl~ide (NE'c) o~r D~Ala.NH2 or zlz~-Gly ~o 6~nhancs
~l~eix ~c:t vi~y~ ~rhese are represe~ed in Table 'I .
~h~ inv~n :lon ~l~o provid~ a number o~ rlovel analo~ue~ o~
~atu~lly oc Icurr~ng gonadotropirl relea~lng ho~n~n~ wh~Ch
lnaluds ~ 3- u~$r~o a~:~ d in th2ir amino a~id s~ anc:~ ~ On~
~artic~ . ~n~logue o~ the ~ nvent~on h~ A ~ur~h~r
~ubsti~ut o~ I ~n tnat Gly. N}{z, WhiCh oc:~u~io~ po~3ition
along t~l I , ~ino ~cld ~ uence, i~ sub8tituted w1 th
~thyl~mld a ~NEt). ~rh~k ~re ~epr~nted iJI Tabl~
To delin~ st~ the func~ional lmpc~r~anco o~ ~he var~ ar~ am~n~
~cidQ in ~ ~o~ltions 5, 7 and ~, ~himaeric analogue~ ~c:cording
to the ln~ en~on ~re test6!d ~or luteinizirs~ hor~one tLdl) ~n~

2029018
.
~olllcl~ sti~ulating hor~one (F~) rRleasing a~t~v~tie~ a~)d
~or r~ l~or bindln~ acti~lty .t~ rat, she~p and chlolcen
pltult~r~ B8 ~
~ho pre~ç ntl Btudy ha~ vestigated ~he actiYl~ias of Gnl~
~nalo~ i4co~po~a~ing ~om~ination~; of the substi~ution~:
~1~5, Trpr I~U8, Gln~ and Tyra ~n n~amm~lian Gn~H ~o~o~her wi~h
th~ ~nc:o~ po~ation o~ 4 ~ Trp4, D-Ly~ ~nd D-~rg~ on r~cepto~
~indlns~ ~ ~d ¦gonadotropin hormone release ln ~he~p, rat ~nl3
~hlcken p. Lt~lltari~
tn th~3 lto 1~,rin~ ~xampl~ tho ~cruo~r~ peptld~
lndiaated 1~ ~ o~ ng an~ substitution ~hat it h~ in lts
amino acl~ I ~ ~quon~ relative ~o ~he amino ~ s~q~ence o~
n~cive ~ 1~ ~ n gonadotropin rele~ing ~ormon4. The
pO8itl0h, in ~he araino ac~d ~equenae, o~ ~he ~ul~titu~ion i#
indi~ted by a nu~nber ~n ~upersaript. I~ no ~lbstitution i~
ind~catçd il 1 arly parti~ular positi~n, ~u~h poE~ition i~
occupled I 1y l~he amino a~id, pre~nt ~n ~h~t po~ on, ~n
r~ativ~ a~ n~lian gonadotropin relea~ng hormon~. Therefo~e,
~c~r ex~mpl ~ Hi~5 ~ T~p~]GnR~ repxe~nts ~n ~nalogue ~f
aalian ~t~dot~opin relea:3ing hormone with ~h~ o a~d
tll~tidins ~n 1pos~tion 5 and the amino acid D T~yptophan i~
pD~ on
~ i
z~8
E~
T~ pcp~ld bl; ! wer~a prepareâ wlth an au~m~ed pxo~r~ on
Bcck=an sylt~ 990 pept~ e ~ynthes1zer. Prot-cted peptlde~
. .

2D291118
: .
. 1 1.
~rere as~ mblec~ ~y Mtand~rd ~ol id-pha~ method~l~y on p~^
~eth~rlb~n hydrylamine~l~ d~vinyl~enzene-styr~r~e copolymer
~esin ~3 , ~ 4) utilising ~0% triflu~roacot~c ~aid in
dlchlorom ~ l~ne for N-termina~ deprot~ctit)n and
d~ loh~ y] ~rbodiim~e for the coupling of tha ~ollow~rlg
~o~-px~'c0 t~ Id amino acids : Gly, Pro, Arg(Tos), ~ln~Xan),
~yr(C12-B 1 , Ly~(C1-~), 1,Qu.H20, I'rp, D-Trp~ Gl~l(OBZl),
Ni~To~) ~ ~er~zl~ a~ w~ll a~ z~pGlu.
~eptide~ Jele ~leaved ~rom the re~in ~nd d~prot~ct~d uslng 1~
~ni~ole 1 ~ ~distilled hydrogen ~luoride ~S)~ Th~ ~ptid~-
~thylamid wa~ cleaved with red~ st~ lled 4thylamins and
depr~tect d wlth hydrogen fluo~ide . ~h~ p~ptld~3~ w~r~
puri~ied o ~x~er 'chan ~6% homogeneity ~ba~ on the r~tio
o~ th~ i te~ Jrated area under the main peak v~. ~he tot~l
lntsgr~t~ ~rea recorded at Z10 nm) b~ p~QparatlvQ 18
r~v~r~ed- h~ ~o hlgh per~or~ance llquid c:hro~a'c~r~phy ~13i~g
~ o . 25M tr ~ethylammonium pho~phate pH ~, ~ 5/~oe~onl~rll~
bu~fe~ ~e~ wlth de~alting 1 n a 0.1% trl~luoroi3c~a~ic
~oid/i~cet nltr~l~. structur2Q o~ peptide~ w~3r~ con~lrmed l~y
~ou~in~ ~ ~i~o ~id analy~is.
~ ~
~nt~rior i~ult~le~ ~er~ ~emo~red from chi~k~n ho~d~ ~old~n
Grovç~ Pou t~y Cc~., c~pe ~own) w~ h h~d be~n k~pt vn ic:e and
wa~h~d w tn d~in~ectar~t ( ' Hibltan~ l; 0 . 596 chlorh~x~dlne
~luconate iin 80~ methanol), wl~hin ~ h o~ d~h. rrhe
pitultarl ~ ~wç~re collected into Dul~eoco~ Modi~i~d Eagl~
~ledlum (t; b~o, G~and Island, NY) buff2r2c~ wi~h 20 m~S HEP}~S
~pH 7 4) t ¦roo~ ~empera'cure, minoed w~h ~ or ~l~de, and
dige~e~ wi~h c:ollagenas~ ~or 1 h at 37~ whilQ undergoing

~ ,91~ 8
9 1
,
c3ontinuou agitation by a ~lowly r~a~ing s~ er. Th~
~oll~g~na a lolution con~l6ted e~f O.g9~ collagenns~ ~W~v) ~5$
~J/m~, ~ort hl~gt~n BiochRmic:al Corp., ~reehold, NJ) and l~mgfl
deoxyrlbo ual~a~e ~M~1~3s ~abox~tories, ~lka~rdt, XN) in HEPES-
BS~ bu~ containing (~ NaCl 137t KC1 5, Na2~P04 0.7,
~EPE~ 25 p~ 7.2), CaCl2 0.3~, glucose 10 ~n~ (w/v) BAS
tfat~y-a~: d j~Xee, Pen~ex ~raction V, Miles Labora~c:ries). At
10-min 1 ~Fval~ th~ cell~ wer~ triturat~d Wi~h ~ 5 ml
p$p~t~e. The c~ uspen~ion was ~nt~l~ug2d ~wia~ ~ 500g
~or S min and t~l~ pellet resuspende:9 each time irl ~u~er A
~NaCl 140; ~M~! K~l 4mM, ll1azHPO4 1.4 mM, glu::ose 8.3 mM, HEP~S
20 mM ~p~ 7J4) and ph~nol red 6 mg/l] to which 0.5 mM EDTA
antl o. 39~ w~lv) l~SA wa~ ad~ed. The c:ell su~penslon wa~ th~n
~ lt~r~d ~rough nylon gauze prlor ~o ~ilution lnto
Dulbeaco~ Y odlfi~d E~gle~ Medium with 10% foetal cal~ nerum
~:ib~o), P~ ni~il lln ~60 m~ tr~ptomycin tlOO mg/l),
~omycln (1 ~/1) and amphoteri~:in B (;~0 Rlg/l) ~nd
di~pen~ed ~ryto pla~tic tiE~SU~ culture well~ ~Falcon, oxnar~,
~A) at a e~ y of 1, 3 pituitary equivalant~ p~r well (
w~ll plat ~1. one pituitary equi~lent reprQ~nta 5.0 to 5.7
105 c~l~ . I T)~e c~ell~ we~e cultur~d ~t 3~t~ 5% C~2 for 24
h, after whiah the medil~m wa~ replacec~ w~th ~r6~
~mphoteri i1 B-free medium. C:ulture wa~ th~n cont~n~ed for
fu~th~r ~4 h.
Prlor to ti~nulation, the cells wer~ w~shed twia~ wlth bu~ar
A ~ontain n~ q CaCl~ ancl ~ SA an~ pre-incubat3d twla~
~or 5 min 1~ the ~;~m~ buf~er. Stiml~la~ion~ wer~ c~rried ou~
~or 30 ~1 ~t ~7C in bu~er A with 1 m~ C~lC12 and 0~1~ BSA.
rhe m~diu m Iw~8 c011~3ct.~d, ~en'crifuged and atored z~t -~0C
un~11 r~d olmn~unoa~:~ay o~ chick~r LH. Mam~Llar~ Gin~H wz~
included nl ~11 bioa:3says a~ a r~ference stand~rd ~or tl~
C~Oll-p~flti rile actlvity o~ the other C;nRH ~nalogu~

20%9~8
~1~ = =~D~ Y ~q;~ bl5;~
~he biol~ ~ l ac:~ivlty Of ~he synthetia GnRH~ WaE~ a~se~e~
usitlg cul turad ~h~ep anterior pltui~ry (~ 8 a~ prQviou~ly
d~cxi~ed ( 1, 2 ) . Ar~terior pituitari~ we~e ~ e~ted ~ra~
~l~eep wlt hln 30 m~n of ~laughte~, diced ~nd in~lbated ln
collagena ~ olu~ion ~ d~arib~d fo~ c:hick~n pituit~ries.
~he cell~ ~ re re~uspended in Minimum ER~ntial Medium -
~aglQ ¢MJ~ M) I ~Wlth Hank's s~lts) (Gi~oo, P~i~lo~, Saotland)
~ntainln~ ~ 110~ ~o~tal calf s~rum (Gibco) ~nd ~ntiblotic~ and
cultured lq5 - .105/dish) ~t 37C ih 5~6 C~2 for 4 or 5 day~,
~qith ~he ~ ~lum b~ing replaaed a~ter 3 days~
~rioX to ~ ul~tion th~ cell3 wer~ washed tw~c~ w~th MEM
a~nta~nir~ ~ ~0 ~6 ~oetal ~al~ BerUm and 4 times w~th serum-
~ree M;~;M I Pqpti:le stimulations (in t~iplica~) wer~
~onduct~ ov~r 2 h in 1 ml ~erum-~ree MEM at 37~ ln 5% ~0;~.
gO0 1 o~ n~sdlum ~rom each te~ was collect~d irlto tuh~
aontalnlnt ~ 100 1 ~ H~PES~SA bu~er, cen~xlfug~d an~ ~tor~d
at -20C u~ ~till radiol~munoa~say. Mammalian Gnl~H wa~ ~ncluded
in all b~c a~y~ a~ ~ referen¢~ ~tanda~d ~or the co~p~ativ~
~otivity e Ip ~hs o~h~r Gn~g ~n~loglle~.
Ov~ h~ L~ r~diaimmuno~says (~A) w~re pe~Po~m~d with
dupl~cate aliqu~t~ o~ conditioned mediu~ tor dllu~ion~
therao~) ~ ro~ stimulAtion ~xperiment:3 ac pr~riou~y ~e~cr1~sd
~), exce~ t ~h~t t~e ~econd ~ntibody wa2~ l~nXed to a~llulo~q:
(~ac~C~l I~70, Wellc:ome P.e~s~ents ~i~nited, seckellham~
Engl~nd). ~riPi~d ovin~ ER- 105~ , gi~t ~om L.~
E~eichert) ~- iodln~ted by the chlor~mine-T m~thod ~n~ ~ree

2029018
! l
I , 11
: I
lodid~ ~i l~r~mov~d on a oellulo~e CF 11 ~Whatman Inc.,
ton, NJ~ colu~n. A ~tandard curve was ~nerated wi~h
~nlabelle ~ ~heep ~H ~NIH~L~-S18) atld anti~um ~DN 15 (gift
fro~ G.D. Ni~hder~ Colorado State Univer~lty) whlch had
t be~n rai~ ~d ~gain~t ~heep LH.
! Chi~ke" L H ~a~ yed a~ previously de~crib~d ~7), RX~ept
that ~he ~e~ond antibody wa~ linXed to cell~lo8~ tSac-
~D70).
ov~ne FSH ~Idioi~munoassay~ employed anti-oFSH-l anti~arum
(~lnal d~ .ut!ion 1:1~0,000), radioiodlnated ~SH~I-l and oFSH-
~P-l as ~ tandard. ~11 rea~ents were ~uppli~d ~y S. ~t~
tnat~on~l ~r~on~ and Pituitary Progr~m, NID~K) a~ utili~ed
in~tru~ :~d. Separation o~ bound ~nd rree 125I-oF~ w~
~chieved i ~tp ~ ~e~on~ antibody conjugated to ~allulo~e tSa4-
70) ~11 ao~pArative studi~s b2tw~n ~n~l~gues w~e
ormed i~ the ~me radiolmmunoassay ~nd th~ lntra~a-~say
coe~iclQl Itlof varlation f~r ~ad~oi~munoas~ys wer~ : 13.7
(chi~en ~ ~1, 4~% ~she~p LH~, 8.3% ~h~sp F~H).
~D~Q~ ~
~h~ ~$ndil ~gjof ~ynthetic vertebr~e gonado~ropln r~le~ing
h~rmone~ ~d An~logues thereof to ~onadotr~in ~eleasing
hormon~ rl ~cqptors in rat ~ntsrior pituita~y m~m~rane~ WA~
i~va~t~g~t ~d¦as previously de~xib~d (l, 2) . In ~he pr~s~nt
~tudy a ~h~p p~ ltary gonado~opin r~ 3~ ng hormos~
~eaept~r ~ ~n~ln~ ay wa~ also dev~loped,
~nterior ~ lltlultarie6 fro~ ad~lt mal~ rat~ ~Long-Ev~n~) o~
a~trated ad~l~ m~e ~heep were homoge~i~e~ in.i~e-cold lO m~
Tri~-HCl b ~fr~r, pH 7.4, ~ontAlning 1 mM dith~t~itol, 1~0
.

, ,. I . l
1~
snM E~A nd O . ~ 9s BSA. The rat pituitz~xy homogenatQ ~a
cent:~iPuc edl at 1~, Ooo x g ~or 30 min ~ 4C to yield a
~nam~ran~ ellet whlch wa~ re~u~pendQd in the ~ri~l{cl bu~fer.
~he ~hoeE pltuitary homog~natQ, however, wa~ c~ntrifug~d ~t
100 x g 5 ¦ rain, 4C) and the ~;up~rnat~nt rec~ntri~uge~ at
3soO x c ~or 10 mln ~t 4C. Th~ r~3nultlng p~llet wa~
re~u~penc ed ¦ in the ~rl~-H~l bu~er. 'rh~ b~ ndlng aE~8~y
compri~q ¦ incu~tiDn of the membr~n~ prepar~tion tO.16 rat ox
o,O~ ~he ~ p~ultary equlvalants/tu~ o,ooo cpm 125I-[~-
~la6-N M~-L~u7, Pro9-NHEt~;nRH ~radioiod~nated by a
m~dl~lcat on ~ the ¢hloraluine-T method ~8) - l3peclPic
~ctivlty yithe se~-di~placement method, lOOO l~oO ~i/ g]
~nd incr~ ~ilng ~on~ent~a~ion~ o~ the te~t p~3ptide~ for ~o min
~t 4~C~ hf a~G~y was pexfo~ed in gla~ te~t-tUb~B ~ 12 X
~5 m~) wl h a tot~ olum~ o~ 0.5 ml lo mM Tx~ lCl ~u~er pH
7 . 4 cont~ ning 1 m~l di~h~ othreitol, 1 mM EDTA and 0.1% BSA.
~h~ lncub ~on w~ t~rminat:ed ~y dilu~ion with 3 ml ic~ co~d
phospha~ bu~f~red salln~, pH 7~ 4, containing 1~ BSA (PB~-
BSA), ~o~, o~ed ~y ~m~ecliate vacuum ~ltrat10n ~chrou~h ~las~-
~ibre ~11 te~ tGF~; Wh~man) pre~ksd ~n PE~S-~SA. The
~ilt~r~ w rq wash~d twice with 3 ml ps~s~E~sA, and the r~ta~ned
~dloac'ci ~1~y ~ount~d. Non-speç~ic bin~lng w~ d~rmln~ad
ln ~che pr se~e c:~ lo 6 M unlab~lle~ Ala6, N ~e~ u7, Pro9-
~IEt~n~H nd 3ub~tracte~ ~rom all samples (~ 1n r~ and 269c
~n sheep3
l~ç~lu ~L~
~1)50 valu fi~ ( concentr~ ns requir~d Por h~lf maxim~
g~na~Otro] )ir~ r~l~a~e in bioa~ays or ~or half m~xim~l
inhibi~o v~ 1~5I~ M~L~u7, Pro~-N~t~GnRH b~ne~lng) o~
¢nE~H ana ogues werc~ determih~3~ uslng a ~our-pa~me~3r,
nonlinear ~q~ve ~itting pro~ram (All~lt), ~oralng ~urv~ to
,
.

20290~8
1~
1~ 13
l l I
~hare ~s ~al and m~ximal value~. ~ value~ wexe ~lculat~d
~rom tho ~50s oy ~hR method o~ Ch~3ng and Pru~ f ~ 9 ) .
stand~rd e~or~ of ~he mean were dRrived from A~ t
~i~ata~ . I Rel~ e potenci~3s wer~ calcul~t~d ~ro~ EO50 and
~d value~ ~ tive to those ~or mammal.tan anE~H. All v~lula8
prQsen~e~ ~r~ th~ mean~ o~ severdl independent experimentf~.
~1~
All o~ :h~ an~o~ues tested had enh~nc~d L~r~3lea~ing
ivity inl c:hlcken pituitar~ ll cultures when comp~r~d
~rith ~na~nm ~llan GnR~. sin~e mammalian Gn~ and chicken Gn~H
in (thQ rel~slng n~rmone ln the chi~k~n h~p~halamu~ have
ilar a :tivi~ie~, ~he analogue~ are ~ mor~ ~tive than
chlcken G nR~ I. Analogues IV, VI, VIII, IX, XV, XVI, ~nd
XVII had r~ative a~tivi~1e8 500~6 or lligh~r compared with
~aal~an ~,~RX an~ most o~ ~he~se ~r~ char~a~r1sQd by havin~
~-amino ~L~ ~id~ p7-Tyr8 ~ubstitution~. In ~h~ep pitu~t~ry c~ll
C:UltUrss, ~L~Llogue~ I, II, XIII and X~v di~pl~L~ enh~nc~d ~-
~e lea~ ing adtivlt~ .
X~eceptor ~ ~inidlng potency of ~:he ~;n~H ohi~eri~ ~Lnalc)gu~ in
~heep arl~ r~t pltuL~ta~y wa~ in general aorre!laLt~a wi1:.h, I~-
~elea~ g p~ter~ in the ~heep pituitary, howeve~,two
classe~ o~ ' ahalo~ueLs emerg~d in wh$s:h l:kL~ r~l~tive ~ynituda
0~ the~ 1 LC5i~f~t~ d~vi~ted signlf~c~antly:
~ Hi ~5~ rp6~ç~nx~ exibi~d highe~r r~ ptor 3: indlng
~tlvlty 1 .hal n I~l-rel~a~in~ act~vl~y. (~ble ~)
2 ~ h~ I analogue~; wi~h a ~rp7-Tyr~ su;:~stitut1on
character ~tically displayed I~-r~ in~ ~Lct~it~ which i~

1 - I 2~9~8 ~1
14
hlgh~r thar ~ ~Lei~ r~l~tive SeCeptor bind~n~ potencie~ ~TablQ
I) .
cortain o~ t~ 1~ an~lo~u~, as ln~ia~ed in T~bl~s 1 and ~,
~howsd pot~ ~nc i0~ f~r FSH rell3ase whiah w~re ~ ar to their
pot~n~le~ ~o ~ L~i rel-al:~, n t c ~heep pltulti~ry.
. . .
,

l~
..
a~~
1. Mill r,¦ R.P., and King, J.~. ~1983) ~g~l~ 113,
1~64 1369
. Mill ~, R.P., ~llkon, ~.C.d~L., Foll~e, B.K., and }~lng,
J.A. ~ i~ 119, 224-~31
I .
3, stew r~ , J, ~., and Young, J . D . ~ 4 ) in ~l~
~, 2nd ~d1~ion~ pp. 55- 5~, Pisrce
~he~ ~ 1 Co ., ~ockf ord , I l l ino ~ ~
4 . ~qerr ~i~eld, R. B. ~ 63~ h~m. SQ~ 5, 2149-
21S4
. ~ivl~ IX/I J., Ka1~er, R., and Galy~n~ 78)
aiQ~ ~ 17, lg27-193B
ll r/ R.P., ~nd Aehnelt, . ~1977) ~ng~ ~ 101,
76~- 6~1
. Poll ~ , ~.X., Scane~, ~.G., and cur~nin~ham, ~ 72)
151~ ~, 52, 359-378
. Nett ~.M., ahd AdamM, T.E. (1~77) ~D~D~CQ~
101, 13 5~ 4
g. Chen ~, ¦Y.c. ar~d Prusof~, W.H. (1973) ~9~4L~
22, 0~9-3108

- 16 20~018
~ O
O .~
I~ o ~
h ::~ ~3
~ '~
~.r
~1¢
~ ~a
O ~
~Vp, ;~
U ~ o r~
O
!~ P~
~''J ~ Y,~
.~.1 ~~ U'i r1 _I a O O ~ r~
~ , ~
O ~ ~ ~
$ ~ ~ 3 i~ ~3
, ~
&
3 3 I ~ ~ h ~ r $ ~ ~ ~ b~
x ' `e
~ ~ a c~
~ ~ ~ W ~ ~ ~ ~ ~ ~ X U ~ --
:' ' . ~ ' , ':
-
'
'

]7
2~29~8
1~ ~ I ~
fi ~ o
i~ ~
.. 1~ .c: ~ o o
~.~ ~ .
h
,~: R
~,~ 1,
,
O O
O ~; ~ Q~
,,,1 3
~1 ~ l i
3 ~ o o !!i~ :
o ~ ~ ~
D,~$~ ~ ~0
~;~ 'C ~ ~C ~3~
~ ~ , :~; ~ I ~ 1~ b
c c c ~ Y a Y
? t~ ~ ~ ~ ~ ~ ~ Q ~ O
Q ~z ~ ~ .~. p, .
x ~ ~ u

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC from MCD 2006-03-11
Time Limit for Reversal Expired 1994-04-30
Application Not Reinstated by Deadline 1994-04-30
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 1993-11-01
Inactive: Adhoc Request Documented 1993-11-01
Application Published (Open to Public Inspection) 1991-05-02

Abandonment History

Abandonment Date Reason Reinstatement Date
1993-11-01
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
ROBERT P. MILLAR
ROBERT P. MILLAR
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 1991-05-01 1 15
Claims 1991-05-01 3 53
Drawings 1991-05-01 1 11
Descriptions 1991-05-01 17 568
Representative drawing 1999-07-21 1 1
Fees 1992-10-29 1 31